Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PNP | P00491 | 4/20 | 0.61 |
| ▸ | LMNA | P02545 | 3/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.56 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | GLA | P06280 | 1/20 | 0.56 |
| ▸ | EIF4E | P06730 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | TOP1 | P11387 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | THPO | P40225 | 1/20 | 0.56 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.56 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.40 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.40 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.40 |
| ▸ | LGALS7; LGALS7B | P47929 | 1/20 | 0.40 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.38 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.38 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12879160 | 1.00 | PNP (0.61) | PNPLMNASMN1; SMN2ADORA1ALDH1A1 | |
| SCHEMBL12879145 | 0.88 | LMNA (0.63) | PNPLMNASMN1; SMN2ADORA1ALDH1A1 | |
| SCHEMBL12879137 | 0.88 | LMNA (0.63) | PNPLMNASMN1; SMN2ADORA1ALDH1A1 | |
| SCHEMBL12879159 | 0.85 | PNP (0.71) | PNPLMNASMN1; SMN2ADORA1ALDH1A1 | |
| SCHEMBL12892516 | 0.85 | PNP (0.71) | PNPLMNASMN1; SMN2ADORA1ALDH1A1 | |
| SCHEMBL1200223 | 0.85 | PNP (0.71) | PNPLMNASMN1; SMN2ADORA1ALDH1A1 | |
| SCHEMBL13352079 | 0.83 | PNP (0.71) | PNPLMNASMN1; SMN2ADORA1ALDH1A1 | |
| SCHEMBL13320531 | 0.83 | PNP (0.71) | PNPLMNASMN1; SMN2ADORA1ALDH1A1 | |
| SCHEMBL10428124 | 0.79 | PNP (0.68) | PNPLMNASMN1; SMN2ADORA1ALDH1A1 | |
| SCHEMBL2841654 | 0.78 | LMNA (0.71) | PNPLMNASMN1; SMN2ADORA1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8466276-B2 | Oligomer conjugates of heteropentacyclic nucleosides | NEKTAR THERAPEUTICS (US) | 2013-06-18 | — | — | US | disclosed |
| US-20110039797-A1 | Oligomer Conjugates of Heteropentacyclic Nucleosides | Nektar Therapetics (US) | 2011-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110039797-A1 | Oligomer Conjugates of Heteropentacyclic Nucleosides | SLC29A2, SLC29A1, GNE | PNP 137/4885LMNA 3873/4885SMN1; SMN2 2799/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.